NDC 0169-8100

ESPEROCT

Antihemophilic Factor (recombinant), Glycopegylated-exei

ESPEROCT is a Kit in the Plasma Derivative category. It is labeled and distributed by Novo Nordisk. The primary component is .

• Product ID: 0169-8100_562f94e8-825f-4d7f-b93c-b783ac3a43bc
• NDC: 0169-8100
• Product Type: Plasma Derivative
• Proprietary Name: ESPEROCT
• Generic Name: Antihemophilic Factor (recombinant), Glycopegylated-exei
• Dosage Form: Kit
• Marketing Start Date: 2019-02-19
• Marketing Category: BLA / BLA
• Application Number: BLA125671
• Labeler Name: Novo Nordisk
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0169-8100-01

1 KIT in 1 KIT (0169-8100-01) * 4 mL in 1 VIAL, GLASS (0169-8101-90) * 4 mL in 1 SYRINGE, GLASS (0169-8008-98) * 4 mL in 1 VIAL, GLASS (0169-8101-11)

• Marketing Start Date: 2019-02-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0169-8100-93 [00169810093]

ESPEROCT KIT

• Marketing Category: BLA
• Application Number: BLA125671
• Product Type: PLASMA DERIVATIVE
• Marketing Start Date: 2019-11-11

NDC 0169-8100-01 [00169810001]

ESPEROCT KIT

• Marketing Category: BLA
• Application Number: BLA125671
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2019-02-19

Drug Details

NDC Crossover Matching brand name "ESPEROCT" or generic name "Antihemophilic Factor (recombinant), Glycopegylated-exei"

NDC	Brand Name	Generic Name
0169-8100	ESPEROCT	antihemophilic factor (recombinant), glycopegylated-exei
0169-8150	ESPEROCT	antihemophilic factor (recombinant), glycopegylated-exei
0169-8200	ESPEROCT	antihemophilic factor (recombinant), glycopegylated-exei
0169-8300	ESPEROCT	antihemophilic factor (recombinant), glycopegylated-exei
0169-8500	ESPEROCT	antihemophilic factor (recombinant), glycopegylated-exei